Skip to main content
Main navigation
About us
About us
Our work
Rationale
IDDO Team
Contact us
Our partners
Governance
Governance
IDDO Board
Data Access Committee
Data sharing
Data sharing
Contributing data
Accessing data
IDDO legal and regulatory documentation
IDDO data sharing registrations
Research themes
Research themes
WWARN
COVID-19
Ebola
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Chagas Disease
Febrile illness
Scrub typhus
Trachoma
Other diseases
Research
Research
Malaria Tracking Resistance
Malaria Clinical Trials Toolkit
COVID-19 LSR Tool
VL Tool
Medicine Quality Monitoring Globe
Medicine Quality Scientific Literature Surveyor
Febrile Illness Surveyor
Publications
Tools & resources
News
User account menu
Log in
Register
Contact
Bandwidth
High
Low
Language switcher
English
Français
Español
Toggle navigation
About us
Our work
Malaria Drug Resistance
Governance
Scientific Advisory Committee
Regional Centres
Team
Tracking resistance
Tracking resistance
ACT Partner Drug Molecular Surveyor
SP Molecular Surveyor
Artemisinin Molecular Surveyor
Vivax Surveyor
Working together
Working together
Collaborator network
WWARN Study Groups
Sharing and accessing data
Partner projects
Tools & Resources
Malaria Clinical Trials Toolkit
WWARN Analytical Tools
Literature Reviews
External Quality Assurance
Online Courses
Procedures
Kelch markers toolkit
Tools & resources
News
News & information
Videos
Impact
Impact case studies
Publications
Search
Search
Search
Evaluating antimalarial efficacy in single-armed and comparative drug trials using competing risk survival analysis: a simulation study
BMC Medical Research Methodology
Published
17 May 2019
Authors
Prabin Dahal, Philippe J. Guerin, Ric N. Price, Julie A. Simpson and Kasia Stepniewska
DOI
https://doi.org/10.1186/s12874-019-0748-2
